Organon & Co | OGN - Ativo Circulante

Preço das Ações
8.83
Mudança Diária
1.92 27.79%
Mensal
37.97%
Anual
-20.91%
Q2 Previsão
8.59




Ativo Circulante Alterar Data
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Celltrion KRW 5.54T 291.68B 2025-09
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 409.44M 4.39M 2025-12
Divis Laboratories Ltd INR 98.43B 2.38B 2025-09
Gilead Sciences USD 19.89B 1.05B 2025-12
Glaxosmithkline GBP 23.59B 390.44M 2025-12
Kangmei Pharma CNY 7.03B 128.34M 2025-09
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Merck USD 47.56B 10.49B 2025-09
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Organigram Holdings CAD 256.54M 28.35M 2025-12
Organon & Co USD 4.7B 82M 2025-09
Ovoca Bio EUR 1.56M 3.39M 2025-06
Pharma Mar EUR 283.41M 40.53M 2025-12
Qiagen NV USD 2B 535.87M 2025-12
Sartorius EUR 1.72B 449M 2025-09
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Tilray USD 729.32M 28.18M 2025-09
Zealand Pharma A/S 15.67B 950.94M 2025-12